Fractional CSO — CNS Translational Medicine Leader

Arphia Partners Ltd; Boston (MA); On-site; USD 207,000 - 413,000; Part time

Job summary

Arphia Partners Ltd. seeks a Consultant / Fractional Chief Scientific Officer to drive a first-in-class CNS programme through preclinical development into IND/FIH stages. The role involves interpreting complex data, shaping translational strategy, and unifying workstreams with external CROs and SMEs.

The initial engagement is fractional, with at least ~20 hours per month, based on Boston access on the East Coast. The relationship could develop into a permanent CSO in the future.

Qualifications

• Deep CNS / neuroscience and translational medicine expertise.
• Experience taking novel programmes from preclinical development into FIH clinical studies.
• Strong understanding of complex animal models and interpretation of preclinical data.
• Experience directing CROs and external scientific SMEs.
• Credibility to engage with investors and represent the scientific strategy externally.

Responsibilities

• Provide scientific direction and leadership for the CNS/translational programme.
• Oversee progression from preclinical science to IND/first-in-human development.
• Coordinate with CEO and external partners to shape translational strategy.

Skills

CNS/Neuroscience expertise

Translational medicine

Preclinical data interpretation

Strategic leadership

External collaboration

Investor engagement

Tools

CRO management

Job description

Arphia Partners Ltd. seeks a Consultant / Fractional Chief Scientific Officer to drive a first-in-class CNS programme through preclinical development into IND/FIH stages. The role involves interpreting complex data, shaping translational strategy, and unifying workstreams with external CROs and SMEs.

The initial engagement is fractional, with at least ~20 hours per month, based on Boston access on the East Coast. The relationship could develop into a permanent CSO in the future.